Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

EISAI

Eisai forms neurology partnership with UCL

Unique ‘therapeutic innovation group’ will research Alzheimer's, Parkinson's and other brain conditions

- PMLiVE

David Prior to chair UK Care Quality Commission

Replaces Dame Jo Williams

- PMLiVE

Frontera London joins IPA

A year after its launch, agency becomes full IPA member

Pharma deals during November 2012

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

- PMLiVE

Boehringer talks More Health on new blog

Pharma company's US team looks to connect with 'social entrepreneurs'

- PMLiVE

Lundbeck and Takeda submit depression drug for US approval

Brintellix could help Lundbeck overcome loss of patent protection for Lexapro/Cipralex

- PMLiVE

Gilead expands in cancer with $510m YM BioSciences deal

Lands JAK inhibitor CYT387

- PMLiVE

Hanover appoints new associate director

Jim Baxter joins from Tonic Life to lead market access and brand communications

- PMLiVE

Lilly plans another trial for Alzheimer’s hope solanezumab

Presses on with another late-stage study for the drug

- PMLiVE

Roche invests €200m in Munich biotech centre

Creates new jobs with expansion of German diagnostic production

- PMLiVE

Word games: ditching the marketing jargon

Phil Bartlett on why he’s an advocate of ditching the jargon… choose your words carefully when you next see him!

- PMLiVE

First wave of CCGs authorised

New NHS groups will serve 10 million people

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links